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Abstract
Purpose—To describe the effects of oxygen fluctuations and supplemental oxygen (SO), stresses
relevant to preterm infants today, on growth factor expression and activation of signaling
pathways associated with intravitreous neovascularization and avascular retina, features of severe
retinopathy of prematurity (ROP).
Methods—Review of articles using 50/10 oxygen-induced retinopathy (OIR) and 50/10 OIR+SO
models
Results—Repeated fluctuations in oxygen increased retinal VEGF even while avascular retina
persisted and prior to the development of intravitreous neovascularization. Hypoxia increased
VEGF120 expression whereas repeated fluctuations in oxygen increased VEGF164. Neutralizing
VEGF bioactivity significantly reduced intravitreous neovascularization and arteriolar tortuosity
without interfering with ongoing retinal vascularization. Repeated oxygen fluctuations led to
retinal hypoxia and increased reactive oxygen species (ROS). Inhibiting ROS with NADPH
oxidase inhibitor, apocynin, reduced avascular retina by interfering with apoptosis. Supplemental
oxygen reduced retinal VEGF concentration and exacerbated NADPH oxidase activation to
contribute to intravitreous neovascularization through activation of JAK/STAT pathway.
Conclusion—Oxygen stresses relevant to those experienced by preterm infants today trigger
signaling of different pathways to cause avascular retina and intravitreous neovascularization.
Keywords
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Introduction
Our laboratory has been interested in the question why blood vessel growth proceeds into
the vitreous, rather than into the retina, in retinopathy of prematurity (ROP). We use oxygen
stresses similar to those experienced by preterm infants who develop severe ROP in modern-
day. We have studied the effects of oxygen stresses on retinal vascular development, growth
factor expression, and signaling pathways involving mostly angiogenesis. We use the rat
model of repeated fluctuations in oxygen developed by John Penn (50/10 OIR model),
because this model has similarities to the oxygen stresses that preterm infants experience in
modern-day neonatal intensive care units and develops an appearance similar to stage 3 ROP
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with intravitreous neovascularization at the junction of vascular and avascular retina (Figure
1). We also study the effect of supplemental oxygen (SO) using the 50/10 OIR+SO model1.
By understanding the causes of abnormal blood vessel growth, we strive to determine
methods to not only inhibit intravitreous blood vessel growth, but also to facilitate
intraretinal vascularization of the previously avascular retina (Figure 2).
Significance
Blood vessel growth into the vitreous precedes the formation of complex traction retinal
detachments in ROP that can lead to complete blindness in preterm infants. Even with
successful retinal reattachment through surgery, vision is often poor2. Therapies to reduce
abnormal blood vessel growth using ablation to the peripheral avascular retina with
cryotherapy3 or laser4 have led to significantly improved visual outcomes.
Features Important in Severe ROP: Avascular Retina and Intravitreous
Neovascularization
Multicenter clinical trials have shown that preterm infant eyes with the largest peripheral
retinal avascular zones have the worst outcomes from ROP5,6. The avascular, hypoxic retina
is believed to be a source of angiogenic factors that cause pathologic intravitreous
neovascularization in some models of ROP7,8. However, what causes avascular retina
initially remains largely unknown. ROP was first described in the 1940’s9 as retrolental
fibroplasia for the appearance of the worst stage (now called stage 5 ROP indicating total
retinal detachment with a retrolental fibrovascular membrane). At that time, there was
inadequate technology to carefully monitor oxygen levels in premature infants in neonatal
intensive care units. Vaso-obliteration of newly formed and fragile retinal vessels from high
oxygen likely played a role in early forms of ROP. However, with improved oxygen
monitoring and recognition of earlier stages of ROP, delayed retinal vascularization has also
been recognized as an important contributor to avascular retina. Delayed retinal vascular
development in bcl2 −/− mice that have a defect in protection against apoptosis, supports the
thinking that increased apoptosis of endothelial cells or their precursors may contribute to
avascular retina10. Other data support apoptosis, or programmed cell death, as a mechanism.
Protection of newly formed capillaries from hyperoxia-induced endothelial death occurs by
giving growth factors like insulin-like growth factor-1 (IGF-1) or a binding protein to IGF-1,
placental growth factor-1, VEGF11–14, or nutritional supplements, including amino acids
(arginyl-glutamine) or omega 3 fatty acids15,16 prior to the hyperoxic insult. We reported
that presumed reactive oxygen species released from activated nicotinamide adenine
dinucleotide (phosphate) (NADPH oxidase) after repeated oxygen fluctuations contributed
to the avascular retina through apoptosis17. Thus, the area of avascular retina is associated
with the severity of human ROP, and apoptosis may contribute to the avascular retinal area.
ROP may differ from other retinovascular diseases associated with avascular retina, such as
proliferative diabetic retinopathy. In ROP, regression of disease often is associated with
intraretinal vascularization into the previously avascular retina. The avascular retina thus
appears able to support intraretinal vascularization in ROP, whereas in diabetic retinopathy,
this appears less often.
Fluctuations in Oxygen: Effects on Retinal Vascular Development and
Modern-day ROP
When ROP was first described in the 1940’s, it was likely a result of high unregulated
oxygen at birth18–20. Several animal models were developed to study the causes of the
disease19,21. These models exposed newborn animals to very high constant oxygen that
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caused vaso-obliteration of newly formed susceptible capillaries. Then following room air
exposure, intravitreous endothelial budding into the vitreous occurred. The results of this
early research led to improvements in oxygen monitoring and the avoidance of high,
unregulated oxygen at birth. ROP virtually disappeared. However, as infants of younger
gestational ages and smaller birth weights survived, ROP re-emerged. Now, rather than high
inspired oxygen at birth, it is recognized that fluctuations in transcutaneous oxygen levels
are also important risks for severe ROP22–27. (The fluctuations in oxygen are proposed to
cause fluctuations in retinal oxygenation and be secondary to changes in both inspired and
blood oxygen concentration resulting from episodes of bradycardia and apnea of
prematurity.)
Rats raised from birth in fluctuations of oxygen rather than room air developed areas of
peripheral avascular retina (John Penn performed this work and developed the rat models for
ROP. Penn's work is discussed elsewhere in this issue). Further, certain extremes and ranges
in oxygen levels led to avascular retina and intravitreous neovascularization at the junctions
of vascular and avascular retina28. Pups cycled between 45% and 12.5% inspired oxygen
every 24 hours, rather than 40% and 15%, had more severe intravitreous neovascularization
and greater avascular retina. When oxygen was cycled between 50% and 10% every 24
hours (50/10 OIR model), the pups develop an appearance similar to that of infants with
stage 3 ROP (compare Figure 1 and Figure 3). In the human preterm infant that develops
severe ROP, Cunningham and McColm found that transcutaneous oxygen levels fluctuated
on a minute to minute basis in preterm infants who developed severe ROP22. The extremes
in oxygen levels were similar to the arterial oxygen concentrations that occurred in rats in
the “Penn 50/10” OIR model. Furthermore, when these oxygen levels were recapitulated in
newborn (not premature) rats with minute-to-minute fluctuations, peripheral avascular retina
occurred, but to a lesser degree than when fluctuations occurred every 24 hours29. Most
other models of oxygen induced retinopathy, including the mouse model30, use high
constant inspired oxygen that causes high blood oxygen concentration31 to induce central
capillary obliteration rather than peripheral avascular retina (see lectin-stained retinal flat
mount of mouse model, Figure 4). Therefore, besides high oxygen at the time of birth, it
appears that in ROP of modern-day, fluctuations in oxygen play a role in the development of
pathologic features of severe ROP, and there is laboratory evidence supporting oxygen
fluctuations with the clinical findings.
Supplemental Oxygen in Modern-day ROP
Animal studies using the kitten model of high hyperoxia32 or the mouse model33 found that
animals recovered in supplemental oxygen rather than in room air had less severe
retinopathy. Based on this, a multicenter clinical trial was set up to determine if
supplemental oxygen vs. conventional treatment in infants who developed prethreshold ROP
would reduce the occurrence of threshold ROP (severe ROP in which the risk of retinal
detachment - stage 5 ROP - approached 50%3). Although the Supplemental Therapeutic
Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP) study found no adverse
effect from supplemental oxygen and perhaps a benefit in a subgroup34, several studies now
report that severe ROP is more common in preterm infants who have had high oxygen
saturations at some points in their management in neonatal intensive care units35,36.
Methods
50/10 OIR model and 50/10 OIR + SO model
All animal studies complied with the University of North Carolina’s Institute for Laboratory
Animal Research (Guide for the Care and Use of Laboratory Animals) and the ARVO
Statement for the Use of Animals in Ophthalmic and Visual Research.
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In the 50/10 OIR model, pups within 4 hours of birth were placed with their moms into an
oxygen-regulated environment (Oxycycler, Biospherix, New York, NY) in which they were
exposed to 50% oxygen for 24 hours followed by 10% oxygen for 24 hours37. This cycle
was repeated 7 times until day 14 (Figure 5). Oxygen levels were monitored daily and
recalibrated as needed. Carbon dioxide in the cage was also monitored daily and flushed
from the system by maintaining sufficient gas-flow and by adding soda lime. Pup number
per litter was maintained between 12 and 14. At postnatal day (p)12, retinal arteriolar
tortuosity developed38,39 and at p14, peripheral retinal avascular retina was ~30% of total
retinal area similar to that seen zone II human ROP (Table 1). At day 14, pups were placed
into room air for 4 days (50/10 OIR model) or into 28% oxygen (50/10 OIR + SO model,
Figure 5). At p18 to p20, intravitreous neovascularization occurred at the junction of
vascular and avascular retina similar to stage 3 ROP (Figure 3 and Figure 4)40. These
features are reproducible and can be quantified and compared (Figure 6).
Specific methods are discussed in papers referenced below. In general, pathologic features
of severe ROP were avascular retina, retinal tortuosity, and intravitreous neovascularization.
Avascular retina was measured using ImageTool (v.3, University of Texas, TX) and the
avascular/total retinal area determined from lectin stained retinal flat mounts. Vessel
tortuosity was analyzed by tracing the vessel extent using ROPtool (version 1.1, from the
University of North Carolina Computer-Aided Diagnosis and Display Laboratory41).
Intravitreous neovascularization was analyzed by counting the number of clock hours
involved or summing areas of neovascularization.. Retinal sections were made from
cryopreserved whole eyes (except for cornea, lens and vitreous) and co-labeled for cell
markers and proteins. mRNA and protein were determined from whole fresh retinas minus
the ora serratas. Systemic (intraperitoneal injections) or intravitreous injections were
performed to test the effects of agents on features and signaling pathways.
Studies and Results
Effects of Oxygen Fluctuations on Angiogenic Factor, VEGF, and Inhibitory Factor, PEDF
Vascular endothelial growth factor (VEGF) is an essential growth factor in retinal vascular
development42,43. It is also important as a survival factor for newly developed vessels and
for adult vascular beds44,45. However, it can be a major factor involved in pathologic
angiogenesis in a number of diseases in animal models and humans, including those
associated with intravitreous neovascularization46,47. A knockout of even one allele of
VEGF or of receptor 1 [VEGFR1 (flt-1)] or receptor 2 [VEGFR2 (KDR, Flk)], is lethal.
Therefore, the effects of VEGF can be studied by blocking the biological actions of VEGF
through inhibitors or antibodies. Pigment epithelial derived factor (PEDF) is also important
in retinal vascular development48, and has been shown to be a potent anti-angiogenic factor
with ability to inhibit VEGF induced angiogenesis48–50,51. Since these two factors are
important in both retinal vascular development and pathologic angiogenesis, we studied the
role of oxygen stresses on the regulation of VEGF and PEDF.
In several animal models using hyperoxia induced vaso-obliteration, investigators found that
retinal VEGF expression was reduced during periods of high constant oxygen51,52 and
increased during relative hypoxia42,43 upon return to room air30 (Figure 4). The increase in
VEGF expression was also associated with angiogenesis during normal vascular
development with physiologic hypoxia42,43. However, less has been studied on the effects of
oxygen fluctuations on the expression of VEGF over time in development using models that
replicate the oxygen stresses experienced by modern-day preterm infants who develop ROP.
We studied the effects of different numbers of oxygen fluctuations on the percent avascular
retina and on the expression of VEGF and of its mRNA isoforms, caused by alternative
splicing of the parent mRNA. The isoforms have been shown to have different biological
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activities53–58. Compared to room air, pups raised in the 50/10 OIR model had increased
avascular/total retinal area at all time points tested [Table 1].
VEGF has several angiogenic isoforms of the parent mRNA. There are at least 5 pro-
angiogenic VEGF mRNA isoforms in humans and 3 in mice that develop from alternative
splicing of the parent gene. The most studied are (with mouse/rat analogs in parentheses)
VEGF189 (VEGF188), VEGF121 (VEGF120), and VEGF165 (VEGF164)59. The isoforms have
different biologic functions based on differences in heparin binding, which determines the
gradient generated53–58. VEGF164/165 is the most prevalent and also increases leukostasis,
endothelial apoptosis, and avascular retina through inflammatory mechanisms in some
models54. VEGF120/121 is soluble and VEGF188/189 is believed involved in endothelial
adhesion and migration60,61. Since VEGF is important in development as well as in
pathologic angiogenesis, we wished to understand whether it was the expression of certain
isoforms that was dysregulated under oxygen stress.. We first determined the effect of
hypoxia versus repeated oxygen fluctuations (i.e., the 50/10 OIR model) on the expression
of isoforms of the parent VEGF mRNA62. A single episode of 10% oxygen at p7 or p14
caused a significantly increased fold change in VEGF120, the soluble isoform, compared to
room air, but not the “pathologic” VEGF164, as determined by relative quantitative PCR. On
the other hand, repeated fluctuations in oxygen caused a greater fold difference in VEGF164
mRNA compared to a single episode of 10% oxygen [Figure 7]. Furthermore, with ELISA
testing, which would measure protein of all isoforms but represent mainly the most
prevalent isoform (VEGF164), there was greater fold increase in VEGF protein following
repeated fluctuations in oxygen rather than after one cycle between 50% and 10% oxygen
(both time points were immediately following hypoxia). We did not find a significant
difference in fold change in mRNA of PEDF between room air- and 50/10 OIR-exposed rat
pups at several time points. However, PEDF expression was greater at early postnatal day
ages than at later ones in the 50/10 model compared to room air62.
We extended these studies to determine whether VEGF expression was increased after
return to room air and preceding the development of intravitreous neovascularization. This
would be analogous to other models of hyperoxia induced vaso-obliteration and
angiogenesis, in which VEGF expression was reduced during vaso-obliteration from
hyperoxia and increased during angiogenesis upon return to room air. Using ELISA, we
measured VEGF protein in retinas from rats raised in room air or the 50/10 OIR model.
However, we found that VEGF was significantly greater than room air at p12 and p14 while
avascular retina was present in the 50/10 OIR model prior to return to room air (Figure 8).
From these studies, we learned that VEGF164 was the most prevalent isoform both in room
air and the 50/10 OIR model. VEGF164 expression was increased by repeated fluctuations in
oxygen whereas VEGF120 expression was increased by hypoxia62. Although VEGF
expression was increased by repeated oxygen fluctuations compared to that in room air,
retinal vascular development was delayed and intravitreous neovascularization occurred.
Gerhardt et al63 injected very high concentrations of VEGF into the vitreous and found that
endothelial tip cells pointed filopodia (believed important in providing guidance cues for
migrating endothelial cells) toward the vitreous. These observations led us to the hypothesis
that the chemotactic force of vitreous VEGF would attract endothelial cells to grow away
from the retina and into the vitreous in diseases with intravitreous neovascularization. We
sought evidence for this hypothesis by measuring VEGF protein in the vitreous and retina of
animals in the 50/10 OIR model. Compared to room air, we found at least 10-fold greater
retinal VEGF at p12, p14, and p18 in the 50/10 OIR model64 (Figure 8; Table 2). However,
in the 50/10 OIR model, the retinal concentration of VEGF at p18 was at least 10 fold
greater than that in the vitreous (Table 3)64, and this finding argued against the hypothesis
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that vitreous VEGF concentration would provide a chemotactic gradient for migrating
endothelial cells.
Effects of VEGF Inhibition on Avascular Retina and Intravitreous Neovascularization in the
50/10 OIR Model
We then wished to determine if inhibiting the bioactivity of VEGF using a neutralizing
antibody to VEGF would affect retinal vascular development or intravitreous
neovascularization. Based on findings that retinal VEGF was greatest at p14 in the 50/10
OIR model64, we chose to inject a neutralizing antibody made against VEGF164 into the
vitreous of rats in the 50/10 OIR model. Compared to a nonimmune IgG control, 50 ng of a
neutralizing antibody to VEGF significantly reduced clock hours of intravitreous
neovascularization (50% reduction) without interfering with retinal vascular development
determined as avascular/total retinal area (Figure 9). This dose reduced phosphorylated
VEGF receptor 2 labeling in retinal cryosections but not phosphorylated VEGF receptor 164.
The evidence supported that inhibition of VEGF signaling through VEGFR2 appeared to
reduce intravitreous neovascularization without further interfering with retinal vascular
development.
Effects of VEGF Inhibition on Tortuosity and Dilation of Retinal Vessels in the 50/10 OIR
model
In the 50/10 OIR model, retinal tortuosity occurs38 and has similarities to human plus
disease, a feature of severe ROP (Figure 10). Historically, the cause of plus disease has been
proposed to be increased blood flow from a peripheral mesenchymal shunt in the region
where intravitreous neovascularization develops42. Chanling et al. found that smooth muscle
cell differentiation was altered under relative hypoxia in a kitten model of hyperoxia induced
vaso-obliteration and proposed that loss of smooth muscle cells in retinal vessels would
contribute to impaired autoregulation of blood flow65. Doppler studies of blood flow in the
central retinal artery showed either reduced or no difference in blood flow in human infants
with or without ROP or with or without plus disease66,67. However, these studies are
difficult in the awake preterm infant, and measurements at the central retinal artery may not
reflect peripheral blood flow, where the mesenchymal shunt is presumed to occur.
Increased blood flow increases shear stress, or the in-line frictional force in a straight vessel.
In tortuous vessels, shear stress is believed greater at the acutely curved portion of the
vessel. Shear stress can activate endothelial nitric oxide synthetase (eNOS), which then can
lead to vessel relaxation and dilation. eNOS can also be activated by hypoxia and VEGF.
Ernest had shown that the kitten retina in oxygen-induced retinopathy models was hypoxic
during relative hypoxia upon return to room air7. We also found that the rat pup retina was
hypoxic in the 50/10 OIR model8 (see below). eNOS−/− mice subjected to hyperoxia
followed by relative hypoxia developed less severe retinopathy, but there was no change in
retinal VEGF levels suggesting that VEGF expression was not triggered by eNOS68.
Therefore, we asked if retinal hypoxia triggered increased expression of VEGF and
signaling through VEGFR2 to then trigger eNOS and retinal vessel dilation, a feature of plus
disease.
We first determined the time points when arteriolar tortuosity occurred in the 50/10 OIR
model by tracing vessels with ROPtool version 1.1, from the University of North Carolina
Computer-Aided Diagnosis and Display Laboratory41. Compared to room air, arteriolar
tortuosity was significantly increased at p12 and p14 at the same time points as VEGF was
increased (Figure 11). To determine if eNOS was increased in the 50/10 OIR model, we
measured western blots for eNOS protein relative to β-actin and phosphorylated eNOS in
the 50/10 OIR model compared to room air. eNOS relative to β-actin was significantly
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greater at p12 and p14 in 50/10 OIR compared to room air retinas. Therefore, eNOS was
expressed to a greater extent at time points when arteriolar tortuosity and VEGF were also
increased (p12 and p14).
To determine if eNOS was a downstream regulator of VEGF signaling, we used a
neutralizing antibody to VEGF at a dose that we previously found effective in inhibiting
intravitreous neovascularization64. Compared to a non-immune IgG control, arteriolar
tortuosity was significantly reduced by the neutralizing antibody to VEGF (Figure 12).
However, neither eNOS nor phosphorylated eNOS was reduced39.
We then asked whether VEGF signaling might be leading to dilation in vessels by altering
the direction of subsequent endothelial daughter cell migration. Previously, we found that
the cleavage planes of endothelial cells during anaphase were disordered when signaling
through VEGFR2 was increased using a flt-1−/−embryonic stem cell model. (flt-1 is the
murine analog of VEGFR1. When knocked out, VEGF cannot bind to VEGFR1 and
therefore causes signaling of VEGF to go through VEGFR2.) When a soluble flt-1 transgene
with a PECAM-1 specific promoter was introduced into the model, restoration of the normal
orientation of the cleavage planes occurred69.
Since we found that inhibition of VEGF signaling through VEGFR2 reduced intravitreous
neovascularization64, we chose to use a neutralizing antibody as the strategy to reduce
VEGF signaling and determine the effect on vessel dilation. To analyze effects on vessel
dilation, we measured the angle between the long axis of the vessel and the cleavage plane
of dividing lectin stained endothelial cells in retinal flat mounts of pups raised in either room
air or the 50/10 OIR model (Figure 13). To determine dividing cells, we stained the cleavage
planes during anaphase using phosphohistone. We also measured endothelial cells by
staining vessels with lectin. By p11, there were few mitoses recognized in flat mounts of
retinas of room air raised pups and most had angles perpendicular to the long axis of the
vessel (predicting vessel elongation). However, in the 50/10 OIR model, there were many
more mitoses noted and a greater proportion was parallel to the long axis of the vessel
(predicting vessel dilation) or disordered (predicting potential disordered angiogenesis). By
Chi-square analysis, there were fewer mitosis planes parallel to the long axis of the vessel
after treatment with a neutralizing antibody to VEGF than after with an IgG control
(p<0.05)39 providing evidence that inhibition of VEGF caused dilated vessels to become
more elongated.
Based on these studies, it appeared that VEGF signaling through VEGFR2 contributed to
arteriolar tortuosity and venous dilation through the alteration of the angle of the mitotic
cleavage planes. eNOS was increased in the 50/10 OIR model but we were unable to find
evidence that it was directly downstream of VEGF at the time points determined.
Effects of Reactive Oxygen Species on Avascular/total Retinal, VEGF expression, and
Intravitreous Neovascularization in the 50/10 OIR Model
Oxidative stress has been linked to ROP through mechanisms related to oxygenation of
retinal tissue in the preterm infant70–73. Reactive oxygen species (ROS) can trigger a
number of signaling pathways17,74. We anticipated that the zone where intravitreous
neovascularization occurred would be a region where abutting vascularized and avascular
retina would create spatial changes in oxygenated and hypoxic retina. (Fluctuations in
oxygen in a model with abutting areas of vascularized and avascular retina may trigger ROS
similar to ischemia-reperfusion injury). To study this, we administered to rat pups
intraperitoneal injections of pimonadazole (Hypoxyprobe), a soluble protein that forms
insoluble conjugates when in an environment of 10 mm Hg oxygen or less. These adducts
can be detected with a fluorescently labeled antibody or quantitated by western blot. We
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visualized where insoluble pimonidazole existed in retinal flat mounts from postnatal day 4
room air raised pups and postnatal day 18 pups raised in the 50/10 OIR model. (Retinal
avascular areas are about 50% in room air at postnatal day 4 and 25% in 50/10 OIR at
postnatal day 18 [Table 1]). In the room air animals even within peripheral avascular retina,
there was little insoluble pimonidazole (Figure 14a). However, insoluble pimonidazole was
present within the peripheral avascular region adjacent to vascularized retina and also in
between retinal vessels centrally in the 50/10 OIR model8 (Figure 14b).
We determined the effects of fluctuations in oxygen on retinal production of end-products of
reactive oxygen species (ROS) and found that lipid hydroperoxides tended to increase in the
50/10 OIR model (Figure 15)17. At day 18, apocynin, which is believed to reduce ROS
through inhibition of the activation of nicotinamide adenine dinucleotide (phosphate)
[NADPH] oxidase, significantly reduced the avascular/total retinal area in the 50/10 OIR
model compared to control (Figure 15b). Cleaved caspase-3, a downstream effector of both
the intrinsic and extrinsic pathways of apoptosis, was also reduced17 providing evidence that
repeated oxygen fluctuations caused apoptosis through NADPH oxidase activation17. These
data were in line with those of previous studies that reported reduced avascular retina in the
50/10 OIR model following supplementation with manganese superoxide dismutase or
vitamins C or E to reduce ROS75,76.
Using cell culture to study the effect of hypoxia on signaling pathways of human retinal
microvascular endothelial cells (RMVECs), we found that RMVECs exposed to 1% oxygen
had activated phospho-Janus Kinase (JNK) compared to room air exposed RMVECs,
although apocynin did not significantly inhibit this. JNK signalng is involved in apoptosis
and this may be a mechanism for reduced vascular support in the retina which we found in
the 50/10 OIR model8.
ROS can also trigger signaling of angiogenesis through VEGF or other pathways in several
models8,77,78. Furthermore, in a meta-analysis of several clinical studies that tested the
antioxidant, vitamin E, a 52% overall reduction in the incidence of stage 3 ROP
(intravitreous neovascularization) was found in infants with ROP79. However, even though
repeated oxygen fluctuations tended to increase ROS, neither the antioxidant, n-acetyl
cysteine or apocynin, reduced intravitreous neovascularization or VEGF expression in the
50/10 OIR model17. Although we and others have found that VEGF signaling pathway is
not the only pathway involved in the development of intravitreous neovascularization80–82,
it is a dominant pathway in conditions in which hypoxia occurs. Retinal hypoxia increased
in the 50/10 OIR model8. There are no viable knockouts of VEGF or its receptors. We
sought a reasonable approach to reduce the effect of VEGF so as to understand the role of
other signaling pathways also important to the development of pathological features of
avascular retina and intravitreous neovascularization in ROP.
Effects of Supplemental Oxygen on VEGF Expression and Intravitreous
Neovascularization (50/10+SO OIR model)
The role of oxygen in ROP is complex. Early in development, high oxygen is toxic to newly
developed vessels and leads to vaso-obliteration. In one study, high oxygen disrupted the
differentiation of precursors to develop into endothelial cells83. However, later in the course
of development, high oxygen had less deleterious effects and even beneficial effects in some
models32. Mice raised in sustained hyperoxia beyond postnatal day (p)12 had less vaso-
obliteration and neovascularization compared to mice exposed to the hyperoxia induced
vaso-obliteration and angiogenesis model33. Also, rats exposed to oxygen fluctuations and
recovered in supplemental oxygen (28%) rather than room air had reduced intravitreous
neovascularization at some but not later time points1. However, the Supplemental
Therapeutic Oxygen for Prethreshold ROP (STOP-ROP) multicenter clinical trial did not
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find an overall significant benefit from supplemental oxygen given to human infants with
prethreshold ROP34. In addition, current clinical studies show that both fluctuations in
oxygen as well as increased inspired oxygen of infants, later in their courses in neonatal
intensive care units, are associated with higher risk of severe ROP22–25,27. Since reducing
oxygen is of concern to brain development in preterm infants, and increasing the inspired
oxygen is a common practice during preterm infant examinations and procedures in the
neonatal intensive care units, knowledge of the effects of supplemental oxygen (SO) on
ROP is important.
We studied the effects of recovery in 28% oxygen following repeated oxygen fluctuations
(50/10 OIR+SO model) compared to 21% oxygen (50/10 OIR model) on NADPH oxidase
activation and the features of avascular retina and intravitreous neovascularization. We
found that supplemental oxygen significantly reduced VEGF retinal concentration to levels
similar to room air raised animals (Figure 16)8. Therefore, using supplemental oxygen in the
model following oxygen fluctuations was a way to reduce the effect of VEGF and study
alternate pathways.
Although VEGF expression was reduced, supplemental oxygen did not reduce the
concentration of conjugated retinal pimonidazole, a marker of retinal hypoxia8. The
presence of retinal hypoxia while VEGF expression was reduced in the 50/10 OIR model
after recovery in supplemental oxygen was unexpected. Our hypothesis is that there is a
mismatch of metabolic demand, which increases as photoreceptors develop, and insufficient
vascular support. Previously, supplemental oxygen was shown to reduce the autoregulatory
effect of retinal vessels in the 50/10 OIR model1. In high oxygen this may result in poor
constriction of retinal vessels and thus high blood flow and retinal arteriolar oxygen
concentration, similar to that suggested in reports in a kitten model of hyperoxia induced
vaso-obliteration and angiogenesis7. We suspect that increased oxygen within the retina may
reduce the stimulus for neurosensory retinal VEGF overexpression, shown by in situ
hybridization to occur in Mueller cells and ganglion cells84. However, as photoreceptor
development occurs, metabolic demand increases and oxygen is required85,86. Although
oxygen would be increased in the retinal circulation, the choroid, which supplies much
oxygen to the eye, is unable to increase oxygen tension in response to supplemental inspired
oxygen in the p15 rat (unlike in the adult)87. Therefore, although metabolism may increase
under greater retinal vascular oxygen, demand may not be met by the choroid. We continue
to pursue this area of study.
In the 50/10 OIR+SO model compared to the 50/10 OIR model, supplemental oxygen
exacerbated NAD(P)H oxidase activation thus contributing to the area of intravitreous
neovascularization8 (Figure 17). We did not find that Akt or ERK were activated in
RMVECs exposed to hypoxia8. We therefore determined whether NADPH oxidase
activation was working through other angiogenic pathways. The Janus kinase-signal
transducer and activator of transcription (JAK/STAT) signaling pathway can lead to
angiogenesis through ROS either through VEGF88,89 or alternate pathways90,91. We used a
chemical compound that potently inhibits JAK2 protein tyrosine kinase. AG490 (LC
Laboratories, Woburn, MA), blocks the constitutive activation of STAT392 and selectively
inhibits the JAK/STAT pathway in rats93. We found that phosphorylated JAK2 and STAT3
were inhibited at p7 and p14 after repeated oxygen fluctuations and at p18 after exposure to
supplemental oxygen in the rat pups. Furthermore, after exposure to supplemental oxygen at
p18, AG490 significantly reduced the area of intravitreous neovascularization compared to
control (Figure 18). Although we found that apocynin significantly reduced phosphorylated
STAT3 in the 50/10+SO OIR model (as well as the area of intravitreous neovascularization),
there was no difference in the phosphorylation of JAK2 by apocynin. Furthermore, neither
apocynin nor AG490 significantly affected retinal VEGF in the 50/10 OIR+SO model.
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However the concentration of VEGF in the retinas in the 50/10 OIR +SO model was 10 fold
lower than in the 50/10 OIR model and at the concentration in retinas of room air raised rats
of the same postnatal day ages94. Thus, supplemental oxygen, which clinically may be
related to more severe human ROP, also permitted us to begin to understand the effect of
other signaling pathways that may contribute to intravitreous neovascularization when
VEGF levels are not elevated.
Summary
We have found that the oxygen extremes and the appearance of the retina in the 50/10 OIR
model mimics ROP seen today and differs from earlier models of oxygen-induced
retinopathy developed to study ROP when it was initially described in the 1940’s. Whereas
hyperoxia induced avascular retina is associated with reduced VEGF in the mouse model52,
avascular retina in the 50/10 OIR model has increased VEGF concentrations compared to
room air at the same time points. Increased signaling through VEGFR2 causes intravitreous
neovascularization, but it is not the sole cause of it. Inhibition of VEGF bioactivity by a
neutralizing antibody to VEGF reduces VEGFR2 signaling and inhibits intravitreous
neovascularization, retinal tortuosity and dilation, without interfering with ongoing
intraretinal neovascularization. But concerns remain because VEGF is a survival factor for
neurons and endothelial cells so use in preterm infants requires careful study.
We found that ROS were increased by repeated oxygen fluctuations and led to increased
avascular retina through NADPH oxidase induced apoptosis. Recovery from oxygen
fluctuations in supplemental oxygen exacerbated NADPH oxidase to contribute to
intravitreous neovascularization, during reduced retinal VEGF, through pathways involving
the JAK/STAT pathway. Therefore, in the complex oxygen environment of the preterm
infant several angiogenic and apoptotic pathways appear involved to lead to avascular retina
through apoptosis and intravitreous neovascularization.
By understanding pathways of avascular retina and intravitreous neovascularization that
involve VEGF or are triggered even when VEGF is not overexpressed, we expand our
treatment possibilities to include safer ones and avoid concerns of inhibiting the survival
aspects of VEGF in the developing infant. Also, the oxygen stresses (oxygen fluctuations,
hypoxia, hyperoxia and supplemental oxygen) are relevant to today's preterm infant. Greater
study of pathways involved during different oxygen stresses may also be important to
determine effective selective treatments.
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a. Zone II with ridge in the nasal periphery of the left eye of a preterm infant showing early
stage 3 ROP, or intravitreous neovascularzation (Retcam image, Clarity, CA).
b. Left eye of preterm infant with stage 3 ROP (intravitreous neovascularization) showing
flat neovascularization that can occur in zone I and posterior zone II ROP. (see inset zoomed
image; Retcam image, Clarity, CA).
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50/10 OIR model at different post-natal day ages (p) mimics what occurs in human preterm
infants. (1) at birth, human preterm infants have incompletely vascularized retina; (2)
approximately 6% of preterm infants born less than 1000 grams in birth weight will develop
severe ROP, at which time treatment with laser is recommended to reduce unwanted
intravitreous neovascularization and consequences of retinal detachment; (3) most preterm
infants will undergo vascularization of the avascular retina and 50% of infants with
threshold severe ROP will also have regression of the intravitreous neovascularization with
ongoing vascularization of the avascular retina. The goal of our lab is to promote
vascularization of avascular retina and to reduce unwanted intravitreous neovascularization.
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A. Lectin-stained retinal flat mount of pup in 50/10 OIR model at postnatal day (p)14 after 7
cycles of oxygen fluctuations between 50% and 10% inspired oxygen showing peripheral
avascular retina, similar to that in zone II ROP.
B. At p18, after return to room air for 4 additional days, intravitreous neovascularization
develops at the junction of vascular and peripheral avascular retina.
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(top). Lectin-stained retinal flat mount of mouse model of hyperoxia induced vaso-
obliteration and angiogenesis at p17 following 5 days of 75% oxygen and 5 days of room air
showing central obliteration of retinal capillaries with endothelial budding (model developed
by Lois Smith).
(bottom). Lectin-stained retinal flat mount of rat 50/10 model of oxygen induced retinopathy
following 7 cycles of oxygen between 50% and 10%, then 4 days of room air exposure,
showing peripheral avascular retina and intravitreous neovascularization at the junction of
vascular and avascular retina.
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Graph of inspired oxygen over time in the 50/10 OIR developed by John Penn and 50/10
OIR+SO models. At postnatal day 14 pups are returned to room air (50/10 OIR) or
recovered in supplemental oxygen (28% oxygen, 50/10 OIR+SO) models. The models have
relevance to human ROP in that the arterial oxygen of pups in these oxygen extremes mimic
the transcutaneous oxygen extremes in human preterm infants that develop severe ROP.
Also fluctuations in oxygen are risks for ROP. The model also develops features similar to
infants with severe ROP of today.
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Lectin-stained retinal flat mount of pup in 50/10 OIR model at postnatal day (p)18 after 7
cycles of oxygen fluctuations between 50% and 10% inspired oxygen and return to room air
for 4 additional days showing what features can be quantified reproducibly in the model
(avascular/total retinal area, clock hours or area of intravitreous neovascularization,
tortuosity of retinal vessels, capillary density within vascularized retina).
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Effect of a single episode of hypoxia on VEGF isoform expression. A: RT-PCR of VEGF
isoform mRNAs in P7 (lane 1) and P14 (lane 3) control animals in room air (RA), and
animals that had a single hypoxic episode of 24 h of 10% oxygen (10% O2) at either P7
(lane 2) or P14 (lane 4). PCR was repeated three times on different experiments and this
result is representative. B: Densitometry measurements using 18S RNA as the control gene.
Samples were assayed in triplicate and error bars are standard deviations. An asterisk (“*”)
indicates p<0.01 compared to respective controls, t test. (permission from Molecular Vision
2004; 10:512–20, http://www.molvis.org/molvis/v10/a63).
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a. VEGF retinal protein from room air raised and 50/10 OIR exposed pups at different
postnatal day ages by ELISA and showing increase in VEGF in retinas prior to development
of intravitreous neovascularization and compared to room air
b. At p18, retinal VEGF was 10-fold that in the vitreous. (permission from Molecular
Vision 2008; 14:345–357, http://www.molvis.org/molvis/v14/a43).
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Clock hours of intravitreous neovascularization and avascular/total retinal areas of lectin-
stained retinal flat mounts from rat pups in 50/10 oxygen induced retinopathy after
intravitreous injection of neutralizing antibody to vascular endothelial growth factor
(VEGFab) or control nonimmune rat IgG. A: Mean clock hours of intravitreous
neovascularization (IVNV)at p18 were significantly decreased by injection of either 25 ng
or 50 ng VEGFab compared to IgG control (ANOVA p<0.001; * posthoc Student’s t-tests
p<0.001 compared to IgG). B: Mean clock hours of IVNV at p25 were significantly
decreased by injection of 50 ng VEGFab compared to IgG control (ANOVA p=0.003; *
posthoc Student’s t-test p=0.003). C: Peripheral avascular/total retinal area as no different in
retinas treated with either VEGFab dose compared to IgG control at p18 (ANOVA
p=0.238). D: At p25, the overall ANOVA for peripheral avascular/total retinal area was
significant (p=0.038). Posthoc testing showed the 50 ng dose of VEGFab was significantly
decreased compared to the 25 ng dose (* posthoc Student’s t-test, 25 ng versus 50 ng,
p=0.038). However, neither dose of VEGFab was significantly different to control IgG.
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(permission from Molecular Vision2008; 14:345–357, http://www.molvis.org/molvis/v14/
a43).
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Retcam image (Clarity, CA) of right eye of human preterm infant demonstrating dilated and
tortuous vessels seen in plus disease, a feature of severe ROP.
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A. Tortuosity indices in retinal arterioles measured in rats raised in room air or 50/10 OIR
model at different postnatal day (p) ages showing increased tortuosity at p12 and p14.
Bottom: Representative lectin-stained retinal flat mount at p14 in room air (B) and 50/10
OIR (C) models. (re-plotted from Investigative Ophthalmology and Visual Sciences; 2008
Jul;49(7):3107–14).
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Arteriolar tortuosity index of retinas from eyes injected with either 50 ng VEGF antibody
(VEGFab) or 50 ng control IgG at p12 and analyzed at p14. (A) The tortuosity index was
significantly reduced in eyes injected with 50 ng VEGFab compared with that in IgG-
injected eyes (ANOVA *P = 0.004, post hoc protected t-test). (B) Examples of retinas from
eyes injected with 50 ng VEGFab and (C) 50 ng control IgG resulted in tortuosity indices of
1.03 ±0.007 and 1.11 ±0.04, respectively. (re-plotted from Investigative Ophthalmology and
Visual Sciences; 2008 Jul;49(7):3107–14).
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Left: Artist diagram showing long axis of vessel and cleavage plane angle. An angle of 90
degrees predicts elongation of the vessel based on the migration of the dividing endothelial
cells whereas an angle of 180 degrees predicts dilation. An irregular group of cleavage plane
angles may be seen in disordered angiogenesis. Right: Lectin stained flat mounted vessel
with cleavage planes drawn in to demonstrate how technique is performed.
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a. Lectin stained retinal flat mount of room air raised postnatal day (p)4 rat pup injected with
pimonidazole 90 minutes before sacrifice. Lectin stains retina vessels (red) and insoluble
pimonidazole conjugates (green) are present in tissue where oxygen concentration is less
than 10 mm Hg. Despite nearly 50% of the retina as avascular, little insoluble pimonidazole
is present.
b. Lectin stained retinal flat mount of postnatal day (p)18 rat pup from the 50/10 OIR model
injected with pimonidazole 90 minutes before sacrifice. Lectin stains retina vessels (red) and
insoluble pimonidazole conjugates (green) are present in tissue where oxygen concentration
is less than 10 mm Hg. Hypoxic retina (green labeling conjugated pimonidazole) is present
in avascular retina and in areas in between vessels within vascularized retina.
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a. Lipid hydroperoxide in 50/10 oxygen-induced retinopathy model. Lipid hydroperoxide
(LHP) levels in retinas assayed at postnatal days 7, 14, or 18 (p7, p14, p18) from pups
injected intraperitoneally (IP) with n-acetylcysteine (NAC) or PBS at postnatal days p2, p6,
and p10 in the 50/10 oxygen-induced retinopathy (OIR) model. Overall ANOVA, p<0.001,
* p=0.012, Bonferroni post-hoc analysis comparing p18 NAC to p18 PBS injected. (n=8
animals at p7 and 4 animals at p14 and p18).
b. Apocynin treatment significantly reduced percent avascular retina at p18 compared to
PBS control. Avascular retinal area and clock hours of intravitreous neovascularization and
capillary densities of apocynin treated pups. A: Percent avascular retinal area in 50/10 OIR
model after intraperitoneal (IP) injections with apocynin once every 24 h from p12 to p17
and assayed at p18 was significantly reduced compared to phosphate buffered saline (PBS)
injected pups (* p=0.017, Student’s t-test; n=11 retinas each). B: Clock hours of
intravitreous neovascularization (IVNV) in retinas from 50/10 OIR model after IP injections
with apocynin once every 24 h from p12 to p17 and assayed at p18 were not significantly
different to PBS injected pups (p=0.26; Mann- Whitney test, n=11).
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c. Cleaved caspase-3 expression in the retinas of 50/10 OIR after IP injection with apocynin
on p12 and p13 and assayed on p14 was significantly decreased compared to retinas from
PBS injected pups (p=0.021, Student’s t-test, n=4). However, no significant difference in
cleaved caspase-3 expression was measured in retinas of pups injected with apocynin every
24 h from p12 to 17 and assayed on p18 compared to PBS injected pups (p=0.78, Student t-
test, data not shown). (permission from Molecular Vision2007; 13:840–53 http://
www.molvis.org/molvis/v13/a92/)
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ELISA of VEGF from pups in 50/10 OIR or in 50/10 OIR+SO models treated with either IP
injections of apocynin (10mg/kg/day) or equivalent volume of PBS from p12-p17 and
assayed at p18. Student’s t-test. (re-plotted from Investigative Ophthalmology and Visual
Sciences, 2008; 49(4);1591–1598.)
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a. Phosphorylated p47-phox, a subunit of activated NADPH oxidase, is increased in the
50/10 OIR+SO model compared to 50/10 OIR model.
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b. Inhibition of ROS from activated NADPH oxidase using apocynin reduces area of
intravitreous neovascularization in the 50/10 OIR+SO model. (re-plotted from Investigative
Ophthalmology and Visual Sciences, 2008; 49(4);1591–1598.)
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Areas of intravitreous neovascularization (IVNV) at postnatal day (p)18 in retinas from the
50/10 OIR+SO model treated with daily intraperitoneal (IP) injections (5mg/kg) of AG490
or PBS starting at p3 and continuing through p17. Top: Mean pixel density in 10 or more
retinas analyzed per group, *p=0.03. Bottom: Flat mount image representative of each
treatment group. (re-plotted from Investigative Ophthalmology and Visual Sciences, 2009;
in press.)
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Avascular/total Retinal Area and Intravitreous Neovascularization at Different Postnatal Day Ages in Room














2* 61.1 82.8 0 0
7** 24.3 51.2 0 0
14 0 32.8 0 0
18 0 23.1 0 9.5
p2 - one 24 hour period of 50% oxygen followed by a 24 hour period of 10% oxygen and processed following the 10% oxygen cycle.
p7 – cycles repeated between 24 hours of 50% oxygen and 24 hours of 10% oxygen until day 7; analysis performed followed 50% oxygen
(reformatted from data from Molecular Vision2004; 10:512–20, http://www.molvis.org/molvis/v10/a63).











































































































































































Room Air 12.22 (2.4) 9.6 (4.3) 16.87 (2.7) 16 (1.0)
50/10 OIR 189.65 (49.7) 298.55 (55.9) 169.94 (32.5) 190 (23)
Values are in pg/mL. () – indicate standard errors.
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